Kim Blackwell

Kim Blackwell

Dr. Kim Blackwell serves as Tempus’ Chief Medical Officer. She joins Tempus from Eli Lilly, where she was Vice President of Early Phase Oncology and Immuno-oncology. Prior to that, she was a Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University, where she directed the Women’s Cancer Program, Strategic Collaborations, and the … Continued

Lauren Silvis

Lauren Silvis serves as Senior Vice President of External Affairs, overseeing regulatory, public policy and government affairs. Silvis most recently served as the Chief of Staff of the U.S. Food and Drug Administration. Prior to that role, she was the Deputy Center Director for Policy in FDA’s Center for Devices and Radiological Health. At the … Continued

Colette Freeman

Colette Freeman serves as Chief People Officer at Tempus. Colette is charged with shaping all strategic functions associated with the current and future employees of Tempus. Her focus will include leading initiatives centered around culture, recruiting, human resources and professional development. Colette has been curating nascent and mature organizations for the last twenty years. Prior … Continued

Joel Dudley, PhD

Dr. Joel Dudley serves as the Senior Vice President for Research at Tempus, where he oversees research operations for emerging clinical areas. Dr. Dudley was Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. He also served as … Continued

Marc Yoskowitz

Marc Yoskowitz serves as Chief Strategy Officer at Tempus. Prior to Tempus, Yoskowitz was Chief Business Officer, Pfizer Essential Health, leading a range of corporate initiatives and businesses within the Pfizer portfolio. Prior to Pfizer, he served as SVP, Strategy and Corporate Development at Hospira, where he led the company’s efforts in these areas and … Continued

Martin Stumpe

Dr. Martin Stumpe serves as the Senior Vice President for Data Science at Tempus. Prior to joining Tempus, he founded and led the Cancer Pathology project at Google, which uses artificial intelligence to increase the accuracy in image-based cancer detection and grading. His team also succeeded in integrating these diagnostics into optical microscopy for real-time … Continued

Eric Singley

Eric Singley serves as the Vice President of Product at Tempus. Prior to Tempus, he was head of product at Triggr Health, a company focused on individualized treatment for addiction recovery. Prior to Triggr Health, Eric spent 10 years at Yelp where he oversaw all of Yelp’s design and consumer-facing product teams, which included mobile, … Continued

Vanessa Rollings

Vanessa Rollings serves as Chief Financial Officer at Tempus, where she is responsible for providing strategic financial perspective and analytical insight. Prior to joining Tempus, Vanessa was CFO of Rightpoint, a technology consulting firm. She has more than 20 years of professional finance experience in all aspects of financial management, investment banking, accounting, and auditing. … Continued

Mike Yasiejko

Mike Yasiejko serves as Chief Commercial Officer at Tempus, where he leads provider and external partner collaborations.  Prior to Tempus, Mike was a Principal at Bain and Company, supporting clients across multiple industries in growth strategy, commercial excellence and performance improvement. He has also advised early-stage emerging technology ventures to accelerate growth and scale operations. He was previously at … Continued

Kimberly Yeatts

Kimberly Yeatts serves as the Vice President of Clinical Lab Operations at Tempus. Prior to joining Tempus, Yeatts worked as the Director of Molecular Assay Development at Med Fusion. Earlier, she worked at Caris Life Sciences where she served in a number of different roles and was responsible for everything from next generation sequencing assay … Continued